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Noninvasive Diagnosis of Irritable Bowel Syndrome via
Bowel Sound Features: Proof of Concept
Xuhao Du, BSc1, Gary Allwood, BSc, PhD1, K. Mary Webberley, BA, MA, PhD1, Andrisha-Jade Inderjeeth, MBBS2,
Adam Osseiran, BSc, MSc, PhD3 and Barry James Marshall, MBBS1,2
INTRODUCTION: Irritable bowel syndrome (IBS) is a common and debilitating disorder estimated to affect approximately

11% of the world’s population. Typically, IBS is a diagnosis of exclusion after patients undergo a costly
and invasive colonoscopy to exclude organic disease. Clinician’s and researchers have identified a need
for a new cost-effective, accurate, and noninvasive diagnostic test for IBS.
METHODS:

Using a diagnostic case-control study, we explored the use of bowel sounds to characterize IBS with
a view to diagnostic use. We recruited participants with an existing clinical diagnosis of IBS or healthy
(asymptomatic) digestive systems. We recorded bowel sounds for 2 hours after fasting and then for 40
minutes after a standard meal.

RESULTS:

We here report our results including our accuracy in characterizing IBS-related bowel sounds and
differentiation between participants with IBS and healthy participants. Leave-one-out cross-validation
of our model developed using the first 31 IBS and 37 healthy participants gave 90% sensitivity and
92% specificity for IBS diagnosis. Independent testing using the next 15 IBS and 15 healthy
participants demonstrated 87% sensitivity and 87% specificity for IBS diagnosis.

CONCLUSIONS:

These preliminary results provide proof of concept for the use of bowel sound analysis to identify IBS. A
prospective study is needed to confirm these findings.

TRANSLATIONAL Our belt and model offer hope of a new approach for IBS diagnosis in primary practice. Combined with
IMPACT:
screening tests for organic disease, it would offer greater confidence to patients and could reduce the

burden of unnecessary colonoscopies for health care systems and patients.
SUPPLEMENTARY MATERIAL accompanies this paper at http://links.lww.com/CTG/A14
Clinical and Translational Gastroenterology 2019;10:e-00017. https://doi.org/10.14309/ctg.0000000000000017

INTRODUCTION
Irritable bowel syndrome (IBS) is a debilitating functional gastrointestinal (GI) disorder with symptoms including altered
bowel habits, abdominal pain, and bloating. IBS is extremely
common, aﬀecting approximately 11% of the world’s population
(1), and is responsible for 50% of gastroenterology clinic visits in
the United States (2). In addition to direct medical costs, IBS also
leads to indirect costs through lost productivity and can severely
impact on an individual’s quality of life (3,4).
The current gold standard for IBS diagnosis is through the
Rome IV symptom-based diagnostic criteria (5). While oﬀering
positive diagnosis, these criteria are unwieldy (6) and do not have
high reliability (7). In addition, a number of organic diseases
share symptoms with IBS, including Crohn’s disease, ulcerative

colitis, and celiac disease (5). Because of similarities in clinical
presentation, many physicians proceed with invasive testing to
rule out organic disease before conﬁrming a diagnosis of IBS (3,8).
Initial screening would usually include baseline blood tests (including C-reactive protein) and stool tests (including fecal calprotectin and culture) for exclusion of infections, celiac disease,
and inﬂammatory bowel disease (IBD) (5). Typically, primary
care physicians also refer patients for colonoscopy and biopsy (3),
although colonoscopy has been found to reveal inﬂammatory
bowel disease in only a small percentage of patients with IBS
symptoms (9).
These invasive tests are a burden to health systems, contributing to lengthy waiting lists for gastroenterological review and
adding to the ﬁnancial costs associated with IBS. Colonoscopies
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are not only unpleasant for patients but carry signiﬁcant risks. A
Dutch study found that colonoscopies carry a small but relevant
risk (aﬀecting approximately 3% of patients) of major events
requiring hospitalization such as perforation, bleeding, or angina
pectoris. They carry a higher rate (approximately 41%) of minor
adverse events such as rectal blood loss and a change in bowel
habits (10). In addition to these risks, the burden on patients is
multifaceted including physical discomfort, psychological distress, and ﬁnancial costs due to time oﬀ-work. Although the
process may provide conﬁdence to physicians, it rarely does so for
patients. Instead, a diagnosis of exclusion can leave patients
confused and reluctant to engage in IBS management (11).
Clearly, there is a need for a new, cost-eﬀective, noninvasive
diagnostic test that provides reliable and reproducible positive
diagnosis of IBS (7). This could be in combination with blood and
stool tests to screen for organic disease for a comprehensive approach. Novel tests on various blood and fecal biomarkers have
been trialed (7). However, none alone oﬀer IBS diagnosis with
a suitably high positive likelihood ratio and suﬃciently low
negative likelihood value. So far, a multifaceted approach with the
use of symptoms, biomarkers, and psychological markers has
been most successful, but it is too complex and time consuming
for the primary care setting (7).
Perhaps forgotten in discussions of IBS diagnosis is the work
conducted around the millennium by Craine and colleagues
(12–14) exploring the use of computerized bowel sound analysis.
Craine’s team used only short recordings, and relatively simple
processing techniques, but had some success in diﬀerentiating
between IBS and healthy study participants. Their results were
less promising with respect to diﬀerential diagnosis between IBS
and Crohn’s disease (13). More recently, Spiegel, Kaneshiro, and
colleagues have developed a tool for analysis of bowel sounds for
the diagnosis and prognosis of postoperative ileus (15,16). They
found a negative predictive value of 81% (16). Their promising
results and advances in computing technology prompted us to
revisit the use of bowel sound analysis for diagnosing IBS. Our
hypothesis was that we could use new signal processing and
machine learning–based techniques to develop a positive test for
IBS based on bowel sound analysis.
We conducted a preliminary case-control study to both gather
data to enable us to characterize IBS through bowel sound features and test the resultant model. The bowel sounds were collected using a belt with an array of vibration sensors. Two periods
of recording were made, one when the participants were fasting
and one during and after food consumption. We developed and
cross-validated a model for characterization of IBS and healthy
bowel sounds using the ﬁrst 31 IBS participants and 37 healthy
participants. We went on to test the model on independent data
gathered from the next 15 participants in each of the 2 groups.
The ﬁndings will need to be replicated in a prospective study to
conﬁrm their clinical utility; however, this is an important ﬁrst
step.
The intended use of the test is in primary care settings. By
oﬀering a positive diagnosis of IBS, we anticipate that it will
greatly reduce the number of colonoscopies and replace the
process of diagnosis by exclusion. It may be used alongside or
instead of Rome IV diagnostic criteria. As with the use of Rome
IV, clinicians may also choose to conduct concurrent screening
tests for IBD and celiac disease. However, in time, we hope to
expand the approach to cover diﬀerentiation from organic
diseases.
Clinical and Translational Gastroenterology

METHODS
Study design

We used a diagnostic case-control design for our study. Participants with IBS and those with healthy digestive systems were
identiﬁed during the recruitment process. Sound recordings for
the index test were gathered subsequently as part of the study.
Participants

Recruitment. We used advertising and media interviews to attract
participants, who were recruited consecutively as they responded
via phone, e-mail, or online survey and met the eligibility criteria,
between May and September 2017. The study was approved by
the UWA Human Research Ethics Committee (study RA/4/1/
8893—January 25, 2017), and all participants provided informed
consent.
Eligibility criteria and reference standards. Eligibility was determined by the use of a short online survey, followed by a more
detailed phone survey. Inclusion criteria common to both groups
were age 18–65 years, body mass index (BMI) above 18.5, and
a good understanding of English.
Inclusion criteria speciﬁc to the IBS group were a formal diagnosis of IBS by a general practitioner or gastroenterologist, IBS
symptoms for at least 6 months and ongoing IBS symptoms, and
the absence of any organic explanation for their IBS symptoms
after colonoscopy within the past 10 years (typically in the past 5
years). This was the reference standard for IBS and was conﬁrmed
by contacting each patient’s doctor. The reference standard did
not specify any particular diagnostic symptom criteria, given that
some participants may have been diagnosed many years previously, but did include negative colonoscopy results, so as to be
highly eﬀective at ruling out organic disease. Anecdotally, we
know that a diagnosis of exclusion, such as this, is common in
Australia.
Inclusion criteria speciﬁc to the healthy group were being
asymptomatic at the time of referral and self-reported “generally
healthy guts.” This was veriﬁed through negative answers to the
questions in Supplementary Table 1 (see Supplementary Digital
Content 1, http://links.lww.com/CTG/A14).
Exclusion criteria common to both groups were a history of
diabetes, eating disorder, kidney disease, neurological disease or
damage, current use of opiates or heavy use of nonsteroidal antiinﬂammatory drugs, a history of surgery of the GI tract (except for
appendectomy or cholecystectomy), a history of organic GI disease including Helicobacter pylori infection, stomach or duodenal
ulcers (not ulcers due to ulcerative colitis), microscopic colitis,
Crohn’s disease, ulcerative colitis, cancer anywhere in the GI
tract, known intra-abdominal adhesions, and diverticular disease,
celiac disease, diagnosed lactose intolerance, or current GI
infection.
Once recruited, the participants visited the Marshall Centre at
their convenience between June and October 2017 to take part in
the study. All were oﬀered a 30 Australian dollars reimbursement
to cover travel expenses.
Index test development and methods

Development of the belt. Abdominal sounds were recorded using
a Zoom H6 Handy recorder (Zoom, Tokyo, Japan) attached to 4
piezo-based sensors placed on the 4 quadrants of the abdomen and
held in place with stretchy Tubigrip, together referred to as the
“belt.” Software was developed for the initial preprocessing that
VOLUME 10 | MARCH 2019 www.clintranslgastro.com

Figure 1 Process flow diagram for gathering data, creation of a machine
learning–based classification model, and the 2 stages of testing.

identiﬁed bowel sounds for extraction. This system has previously
been described following use for recordings of bowel sounds and
detection of the migrating motor complex (MMC) (17).
Two clinicians blindly and independently listened to a library
of recordings made from the belt. This consisted of 18 putative
bowel sounds as identiﬁed by our system and 8 sounds categorized as nonbowel sounds (non-GI origin or environmental
noise). The clinicians each made a judgment as to whether they
were bowel sounds or not based on their clinical experience.
There was 100% concordance between both clinicians and the
extraction software.

Recordings for model development and validation. Participants
fasted from 9 PM the night before recordings and did not consume
water from midnight, except to take their regular medications.
Recordings took place in a nonclinical setting at the Marshall
Centre on the QEII Medical Centre site. Participants sat quietly in
armchairs and had access to the internet and reading material. If
a participant failed to fast, or complete the full recording session,
they were excluded.
Two-hour recordings of bowel sounds began between 9 AM
and 9.30 AM. The participants then had a short break. At the start
of the second recording period of 40 minutes, participants received a standard meal: 2 slices of whole meal toast with a portion
of butter (or a single banana if unable to tolerate toast) and a glass
of water. No adverse events occurred.
Signal processing and feature extraction. The 160 minutes of
recordings, from all 4 channels of each participant, were sampled
at 44.1 kHz, equating to approximately 1.6 billion data points.
It is impractical to input this amount of data directly into
a machine learning model for training. Hence, signal processing was performed to extract features from the data set and
reduce the sample’s dimensions. The signal processing procedure began with identiﬁcation of bowel sounds (17). Subsequently, frequency-domain and time-domain features were
extracted from each bowel sound, and the approximate location of origin of each bowel sound was determined. The features included many previously identiﬁed in the medical (18)
and biomedical engineering literature (19) and novel features
we developed through our modeling of bowel sound generation (20). The basic process ﬂow of the methodology for
gathering the data and creating a machine learning model is
presented in Figure 1.

Figure 2 Participant flow for the study.
American College of Gastroenterology
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Table 1 Demographics of healthy participants

Model

Male

Female

Total

Age range

Mean age

BMI range

Mean BMI

14

23

37

20–63

43.9

18.6–28.4

24.3

5

10

15

18–62

26.7

18.9–31.9

22.5

19

33

52

18–63

38.9

18.6–31.9

23.8

Test
Overall

BMI, body mass index.

Feature analysis, model development, and cross-validation.
Recordings from the ﬁrst 31 IBS and 37 healthy participants were
used to build a model for dichotomous categorization.
The sample sizes selected were limited by time and recruiting
constraints. However, similar numbers have been used successfully in the past for proof-of-concept studies (21,22).
Logistical regression analysis was used to identify the optimal
array of features most strongly associated with the 2 classes. The
model provided an IBS Acoustic Index, with values 0.5 and above
predicting IBS, and values below 0.5 predicting healthy, with no
indeterminate results. This was compared with the previous
clinical diagnosis (reference standard) for each participant to
assess accuracy. The model was further ﬁne-tuned using test
results from leave-one-out cross-validation (LOOCV). This iterative process was repeated until accuracy plateaued. Internal
evaluation of the optimal model’s performance was provided by
the ﬁnal LOOCV analysis. The optimal model was subsequently
subjected to other k-fold cross-validation techniques and bootstrapping to allow additional evaluation.
Independent testing

The diagnostic accuracy of the optimal model of the IBS Acoustic
Index (the index test) was subsequently tested independently.
This independent test was undertaken using the next 15 IBS
participants and 15 healthy participants, with performers of the
index test blinded to the clinical condition of participants (reference standard). The output of the model (allocation to the IBS
or healthy group) for each participant was subsequently compared with the previous clinical diagnosis (reference standard) by
another researcher. The reference standard had been undertaken
before the study and hence was also performed blinded to the
index test results.
Further validation of the cross-validation testing is provided if
the independent test results lie inside the conﬁdence interval of
the LOOCV results.

of both the cross-validation and the independent testing were
recorded in 2 3 2 contingency tables. We subsequently calculated
sensitivity, speciﬁcity, negative predictive value, positive predictive value, likelihood ratio for positive test results, and likelihood ratio for negative test results for the index test on each
data set.
We investigated whether the accuracy of the test diﬀered for
older participants (over 55 years) vs younger participants, different sexes, healthy range vs high BMI, and for the diﬀerent
subtypes of IBS using Fisher exact tests and a signiﬁcance level of
0.05. Analysis was performed in R (23).
Impact of food consumption on sounds

We assessed the eﬀect of food consumption on bowel sounds. We
investigated changes in the number of bowel sounds per second
and the summed amplitude of bowel sounds and looked for signiﬁcant diﬀerences (alpha 5 0.05) related to the timing of recording relative to food consumption (fasted or fed) and the
presence or absence of IBS and an interaction using a linear mixed
model performed using the lme4 package (24) and analyzed with
the car package (25) using R (23). For these analyses, individuals
were coded as a random variable, and IBS status and food consumption were ﬁxed eﬀects.

RESULTS
Participants

We received 268 enquiries from potential participants. The
longer phone survey and subsequent enquiries to physicians
revealed that many did not meet our inclusion criteria. Ultimately, 68 participants undertook the index test for model
building, and 30 participants were included in the independent
testing. The ﬂow of participants through the study, including
reasons for lack of inclusion, exclusion, or lack of index test (IBS
Acoustic Index), and the index test results for the 2 groups are
provided in Figure 2.

Measures of accuracy

Demographics

The belt provides a dichotomous output based on the IBS
Acoustic Index: a prediction of either IBS or healthy. The results

The demographic and clinical characteristics of the healthy and
IBS groups are given in Tables 1 and 2, respectively. There were

Table 2 Demographics of IBS participants
Transgender

Male

Female

Total

Age range

Mean age

BMI range

Mean BMI

IBS-M

IBS-D

IBS-C

Model

0

5

26

31

22–65

39

18.8–36.7

24.9

18

8

5

Test

1

0

14

15

25–55

41.7

20.3–39.4

25.5

11

4

0

Overall

1

5

40

46

22–65

40.8

18.8–39.7

25.1

29

12

5

BMI, body mass index; IBS, irritable bowel syndrome.
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Table 3 Performance of the IBS Acoustic Index model in
predicting IBS, as assessed by leave-one-out cross-validation of
the optimal model
Condition
IBS

Healthy

Total

IBS Acoustic Index prediction
IBS
Healthy
Total

Table 5 Evaluation measures of the irritable bowel syndrome
Acoustic Index model derived from 7 different k-fold crossvalidation methods
k

Accuracy, %

Sensitivity, %

Specificity, %

LR1

LR2

3

82.4

87.1

78.4

6.5

0.153

5

83.8

80.6

86.5

6.0

0.223

28

3

31

10

83.8

80.6

86.5

6.0

0.223

3

34

37

15

89.3

90.3

89.2

8.4

0.109

31

37

68

20

90.8

90.3

91.9

11.1

0.105

30

90.5

90.3

91.9

11.1

0.105

68

91.2

90.3

91.9

11.14

0.105

IBS, inflammatory bowel syndrome.

more female participants than males in both groups reﬂecting
their willingness to participate and the fact that women are more
likely to report IBS symptoms (1). We had 1 transgender participant, who was in the process of transitioning from female to
male. The mean age and mean BMI were similar in the 2 groups.
IBS-M was the most common IBS subtype. The subtype was
generally based on patient-reported preponderance of symptoms,
rather than a clinical diagnosis.
Model and test results

Model building and cross-validation. The optimal model incorporated both time-domain and frequency-domain features
and their statistical distributions. The features were derived from
both the ﬁrst recording during the fasted state and the second
recording after food consumption and from recordings at all 4
quadrants (26). Two key features were related to the rate of
contraction and the motility of the gut, the component interval
time, and the burst number. These have been described previously in our mathematical model of bowel sound generation
(20). Amplitude during the fasting recording was also an important feature. Amplitude (or more precisely, a sound index
describing the summed amplitude) has previously proved useful
in determining the cycles of the MMC (17), and it is known that
the MMC changes with IBS (27). Other features were derived
from the frequency-domain and relate to the spectrum shape and

LR1, likelihood ratio for positive test results; LR2, likelihood ratio for negative
test results.

bandwidth, waveform shape, and the subband energy ratios of the
bowel sounds.
The LOOCV analysis demonstrated both high sensitivity
and speciﬁcity for the optimal model (Tables 3 and 4). The
overall accuracy, positive likelihood, and negative likelihood of
the trained model were 91%, 11.0, and 0.11, respectively
(Table 4).
Other k-fold cross-validation methods provided overall accuracy values ranging from 0.82 to 0.91 (Tables 5 and 6). The
bootstrapping results from 300 repetitions were also similar
(Tables 6 and 7).
Independent test. The IBS Acoustics Index model performed well
on the independent test, demonstrating 87% sensitivity and
speciﬁcity (Figure 3, Tables 8 and 9). The 2 groups were generally
separated by a large margin under the model (Figure 3). All the
accuracy measures were located inside the 95% conﬁdence
intervals for the corresponding LOOCV results (Tables 4 and 9).
There was no signiﬁcant association between sex (male or
female), IBS subtype (IBS-D or IBS-M), age (.55 years or not),
and BMI (healthy range or 25 and over) and the accuracy rate of
the test determined in the independent testing group (Fisher exact
test P values were 1, 1, 0.25, and 1, respectively). However, it
should be noted that the power was extremely low because of
small samples of male, IBS-D subtype, and older participants
(Tables 1 and 2).

Table 4 Evaluation measures of the leave-one-out crossvalidation for the irritable bowel syndrome Acoustic Index model
Evaluation measure

Value

95% CI

Sensitivity

90%

75.1–96.7

Specificity

92%

78.7–97.2

PPV

90%

75.1–96.7

NPV

92%

78.7–97.2

Accuracy

91%

81.8–96.7

LR1

11.14

3.74–33.16

LR2

0.11

0.04–0.31

CI, confidence interval; LR1, likelihood ratio for positive test results; LR2,
likelihood ratio for negative test results; NPV, negative predictive value; PPV,
positive predictive value.

American College of Gastroenterology

Table 6 Performance of the IBS Acoustic Index model in
predicting IBS, as assessed by bootstrapping (300 repetitions) of
the optimal model
Condition
IBS

Healthy

Total

8234

1,059

9,293

Healthy

1,066

10,041

11,107

Total

9,300

11,100

20,400

IBS Acoustic Index
IBS
Prediction

IBS, inflammatory bowel syndrome.
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Table 7 Evaluation measures of the irritable bowel syndrome
Acoustic Index model derived from bootstrapping (300
repetitions)

Table 8 Performance of the IBS Acoustic Index model in
diagnosing IBS in the independent test
Condition

Evaluation measure

Value

95% CI

IBS

Healthy

Total

13

2

15

IBS Acoustic Index

Sensitivity

89%

87.9–89.2

Specificity

90%

89.9–91.0

IBS

PPV

88.6%

87.9–89.2

Prediction

NPV

90.4%

89.8–90.9

Healthy

2

13

15

90%

89.2–90.0

Total

15

15

30

Accuracy
LR1

9.28

8.759–9.832

LR2

0.13

0.12–0.134

CI, confidence interval; NPV, negative predictive value; PPV, positive predictive
value; LR1, likelihood ratio for positive test results; LR2, likelihood ratio for
negative test results.

Impact of food consumption on sounds

Bowel sound density was signiﬁcantly higher for the healthy
individuals than the IBS participants (x2 5 4.04, P 5 0.045;
Figure 4) and after food consumption (x2 5 56.6, P , 0.001;
Figure 4), but there was no signiﬁcant interaction between IBS
status and the eﬀect of food (x2 5 0.23, P 5 0.629).
Similarly, more higher amplitude sounds were recorded from
study participants after eating (Figure 5). There was a signiﬁcant
diﬀerence in the summed amplitude between the 2 recording
periods (x2 5 22.17, P , 0.001) and in IBS individuals relative to
the healthy group (x2 5 8.02, P 5 0.005). Again, we did not ﬁnd
a signiﬁcant interaction between IBS status and the eﬀect of food
(x2 5 3.68, P 5 0.055).

DISCUSSION
A new model

We successfully developed a logistic regression machine learning model that characterized healthy and IBS conditions based

IBS, inflammatory bowel syndrome.

on a calculated IBS Acoustic Index derived from 26 bowel
sounds features. Both internal validation using the data set used
to build the model (LOOCV, other k-fold cross-validation
methods and bootstrapping) and external validation (independent testing on new participants) showed high levels of
accuracy for the model.
Our approach was innovative with regard to the methods of
bowel sound analysis used. Previously, Craine’s research group
had used short recordings of 2 minutes and only simple sound
features. They used the sound-to-sound interval and the proportion of lower frequency sounds for characterization of IBS
(12,14). Like Craine et al. (12), we found that there was an increase
in bowel sounds after feeding. We also found that there were
generally more louder sounds immediately after food consumption. However, our recordings were much longer, and we used
a much broader range of features (8 time-domain and 18
frequency-domain features) in the ﬁnal model (26). Sounds are
generated as the contents move through the entire length of the
digestive system, especially by the movement of gases through
valves (20,28). Given that IBS corresponds with changes in gut
motility, the amount of water, and the gases in the contents, it is
unsurprising that a variety of sound features characterize this
condition. We discovered that 3 key features, the amplitude,
burst, and the component interval time, which relate to the MMC

Figure 3 Irritable bowel syndrome Acoustic Index results for the 30 consecutive independent test participants.
Clinical and Translational Gastroenterology
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Table 9 Accuracy measures for the irritable bowel syndrome
Acoustic Index in the independent test using 15 irritable bowel
syndrome participants and 15 healthy participants
Accuracy measure

Estimate

95% CI

Sensitivity

87%

62.1–96.3

Specificity

87%

62.1–96.3

PPV

87%

62.1–96.3

NPV

87%

62.1–96.3

Accuracy

87%

LR1

6.5

1.762–23.979

69.3–96.2

LR2

0.15

0.042–0.568

CI, confidence interval; LR1, likelihood ratio for positive test results; LR2,
likelihood ratio for negative test results; NPV, negative predictive value; PPV,
positive predictive value.

and motility, contributed greatly to the model (17,20). Further
work is needed to elucidate exactly how all the features relate to
the IBS condition.
We also used a method of machine learning, which has been
applied widely in other ﬁelds, but has not previously been used
to build models enabling bowel sound analysis for diagnosis.
We used logistic regression–based machine learning (a simple
artiﬁcial neural network). Other researchers have used other
neural networks and wavelets (29), autogressive moving
average (AMRA)-based machine learning (30), a hybrid expert system (31), a fuzzy logic system (32), a back propagation
neural network (33), and a Bayesian classiﬁcation method (15)
to either identify bowel sounds or for diagnosis of GI
conditions.
Implications for clinical practice

The current gold standard for diagnosis of IBS is a positive diagnosis arrived at using the Rome IV criteria. A positive diagnosis
builds conﬁdence in the diagnosis for the patients, improves the
clinician-patient relationship, and, hence, sets the groundwork

Figure 4 Quantity density distribution. The distribution of 46 irritable bowel
syndrome participants and 52 healthy participants across bowel sound
quantity density (bowel sounds per second) for the 2 recordings (120
minutes fasting and 40 minutes fed) from the upper right quadrant. The
distributions were smoothed to a normal distribution.
American College of Gastroenterology

Figure 5 Summed amplitude distribution. The distribition of 46 irritable
bowel syndrome and 52 healthy study participants across summed
amplitude values for all bowel sounds recorded at the lower right quadrant,
during the fed and fasted periods. Summed amplitude values were scaled
to compensate for the longer duration of the recording made during the
fasting period. The distributions were smoothed to a normal distribution.

for better management (11). Furthermore, the criteria are less
invasive and costly than using colonoscopy to diagnose IBS
through exclusion.
However, it has been suggested that although symptom-based
diagnostic criteria may be useful for participant recruitment to
clinical trials, they are less relevant to clinical practice. The criteria
are seen as unwieldy, and validation studies suggest that they only
perform modestly well in identiﬁcation of IBS, especially sensitivity (34).
Researchers have investigated other options, but none are yet
considered practical for or have been adopted in widespread
clinical practice. In the most recent systematic review of IBS diagnosis, Sood et al. (7) reviewed the accuracy of diagnosing IBS
with symptoms, biomarkers, and/or psychological markers. Using any single method provided only modest performance.
Approaches combining symptoms and markers, while complex,
showed best performance. However, no one combination method
met best standards for accuracy of both positive and negative test
results.
Our results indicate that sound analysis may oﬀer a new
and accurate method for positive diagnosis of IBS. Our belt
and model oﬀered both high sensitivity and high speciﬁcity for
IBS in both internal cross-validation analysis and for independent test cases when diﬀerentiating between healthy
and IBS individuals. Furthermore, the belt is noninvasive and
easy to use.
The intended use of the test is in primary care. It may oﬀer an
alternative to the Rome IV diagnostic criteria, but may also be
used in combination with them. As with Rome IV, many clinicians would also choose to conduct baseline blood tests (including
C-reactive protein) and stool tests (including fecal calprotectin
and culture) for exclusion of infections, celiac disease, and inﬂammatory bowel disease (5). Such an approach provides an
alternative to colonoscopy and the process of diagnosis by exclusion for IBS for patients without any red ﬂags. Future work
may also allow expansion of the sound analysis approach to diagnosis of organic diseases, such as celiac disease and inﬂammatory bowel disease.
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Study limitations

Ours was a preliminary study. We used a case-control design
including healthy participants. Such studies are generally
regarded as less reliable than cross-sectional prospective studies
because of spectrum bias. However, it is a good starting point
and oﬀers proof of concept that a machine learning approach
can provide a new method to characterize GI conditions, such
as IBS.
The sample sizes were limited by time and recruiting constraints. However, similar numbers have been used successfully in
the past in other proof-of-concept studies to characterize pathological conditions using a machine learning approach (21,22).
Our results (especially for external validation) exhibited large
conﬁdence intervals indicating statistical uncertainty. However,
the fact that we found consistent results with multiple methods of
internal validation (multiple k-fold cross-validation analyses and
bootstrapping), and independent testing oﬀers increased conﬁdence in the accuracy of our results. These methods included
LOOCV, which is a particularly rigorous approach for internal
validation.
We included study participants with a range of IBS subtypes
and from a wide of ages (18–65 years) and BMI values
(18.5–40.5). These are broad, but we cannot currently generalize
beyond these ranges. Certainly, bowel motility is known to decrease with age, and this could impact on the utility of the belt for
IBS diagnosis in the elderly. In addition, the majority of our
participants were younger than 55 years (with only 2 aged 55
years or older in the independent testing group). We had also had
limited numbers of male participants (5 in the independent
testing group). It would be valuable to reassess the eﬀect of age,
sex, and BMI on the accuracy through a larger study with increased power.
Similarly, we had relatively few study participants with selfreported constipation-predominant IBS. We were unable to assess the eﬀect of subtype with a high level of power. In addition,
our assessment of subtype was based on self-report of predominant symptoms. Use of the Rome IV criteria for this assessment would be preferable, as would be direct comparison to
the Rome IV criteria generally.
We had a wide range of exclusion criteria including comorbidities that may aﬀect bowel motility and GI conditions. Additional research is needed before we can generalize to these groups.
Our belt and model oﬀer hope of a new, more accurate alternative for positive and noninvasive diagnosis of IBS in primary
practice. Further cross-sectional prospective studies in the primary care setting with a ﬁeld prototype are needed for validation,
but the sensitivity and speciﬁcity demonstrated in this preliminary study are excellent. Expanding the capabilities of the belt
to allow diﬀerentiation between IBS and other diseases would
oﬀer even greater impact.
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Study Highlights
WHAT IS KNOWN

3 IBS is typically a diagnosis of exclusion after patients undergo
colonoscopy to exclude organic disease.

3 There is a need for a new cost-effective and noninvasive test
for positive diagnosis of IBS.

WHAT IS NEW HERE

3 We developed a machine learning–based model to
3

characterize IBS and healthy participants based on bowel
sound features.
We achieved proof of concept. Our independent testing
demonstrated 87% sensitivity and specificity in identifying
IBS.

TRANSLATIONAL IMPACT

3 The results indicate real promise in the use of bowel sound
3
3
3

analysis for the positive diagnosis of IBS. The approach could
be used in combination with existing screening tests for
organic disease.
A positive test result would improve the confidence of patients
in the diagnosis, thereby creating a better foundation for
management.
The results also bring potential to reduce the burden of
unnecessary colonoscopies.
We hope in the future to expand the use of sound analysis to
identification of organic disease for even greater clinical
impact.
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